Medical News Today: What to know about non-Hodgkin lymphoma
This article looks at their types, symptoms, diagnosis, and treatment. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 11, 2019 Category: Consumer Health News Tags: Lymphoma Source Type: news
Monsanto's former CEO ordered to testify in St. Louis Roundup trial
Former Monsanto Co. Chairman and CEO Hugh Grant has been ordered to testify in persons at a Roundup trial in St. Louis in January.
Grant, who led St. Louis-based Monsanto from 2003 until the company was sold to Bayer AG of Germany for $63 billion in 2018, was subpoenaed by lawyers for plaintiff Sharlean Gordon, who contends the Roundup weedkiller caused her non-Hodgkin lymphoma. The trial is scheduled to begin Jan. 27 in St. Louis County Circuit Court.
Grant's lawyers have been fighting the subpoena,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 10, 2019 Category: Biotechnology Authors: Greg Edwards Source Type: news
Lenalidomide/Rituximab Combo Improves PFS in Subgroup of Patients with NHL
Treatment with lenalidomide and rituximab improved progression-free survival, compared with placebo in patients ≥70 years old with indolent non-Hodgkin lymphoma. (Source: CancerNetwork)
Source: CancerNetwork - December 9, 2019 Category: Cancer & Oncology Authors: Gina Columbus Source Type: news
No radiation needed for many aggressive non-Hodgkin's lymphoma patients
(SWOG) Most people diagnosed with the most common type of non-Hodgkin's lymphoma can safely skip radiation treatment after a clear PET scan, according to new clinical trial results released today at the 61st American Society of Hematology (ASH) Annual Meeting. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 8, 2019 Category: Cancer & Oncology Source Type: news
An Off-the-Shelf Drug to Rival CAR T Cells:'Very Exciting'An Off-the-Shelf Drug to Rival CAR T Cells:'Very Exciting '
A novel bispecific antibody, mosunetuzumab, has shown complete remissions in patients with poor prognosis non-Hodgkin ' s lymphoma, even those previously treated with CAR T cells.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 7, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Roche announces new data on novel CD20-CD3 bispecific cancer immunotherapies in people with difficult-to-treat lymphomas
Roche today announced new data on two investigational CD20-CD3 T-cell engaging bispecific antibodies, mosunetuzumab and CD20-TCB, in people with relapsed or refractory (R/R) B-cell non-Hodgkin lymphoma (NHL). (Source: Roche Investor Update)
Source: Roche Investor Update - December 7, 2019 Category: Pharmaceuticals Source Type: news
Lymphoma patients may have new path to remission, even when CAR T therapy fails
(University of Pennsylvania School of Medicine) A new, experimental immunotherapy can put patients with B-cell non-Hodgkin lymphoma (NHL) that is resistant to or has come back after multiple other therapies, including CAR T therapy, into remission. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 7, 2019 Category: Cancer & Oncology Source Type: news
Married couple and son, 17, ALL battling cancer and have put their family restaurant up for sale
Kathy Desclefs, of Jacksonville, Florida, has been battling non-Hodgkin's lymphoma for five years. This year, her husband Benoit and her son Luke were also diagnosed with cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - December 5, 2019 Category: Consumer Health News Source Type: news
FDA Takes Action to Reduce EtO Use
Shutdowns earlier this year of two facilities that use ethylene oxide (EtO)Â to sterilize medical devices prompted FDA to monitor for supply shortages in the industry because EtO is such a popular sterilization method for medical devices. This week the agency revealed steps it will take to reduce medtech's reliance on EtO sterilization.
EtO is a flammable, colorless gas used to sterilize equipment and plastic devices that cannot be sterilized by steam, such as medical equipment. In fact, about half of all sterilized medical devices undergo sterilization using this gas. Breathi...
Source: MDDI - November 25, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Sterilization Regulatory and Compliance Source Type: news
Radiation From CT Scans Linked to Thyroid Cancer, Leukemia
Elevated risk stronger in women than men; risk for non - Hodgkin lymphoma increased in patients ≤ 45 (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 21, 2019 Category: Cancer & Oncology Tags: Endocrinology, Family Medicine, Internal Medicine, Emergency Medicine, Oncology, Radiology, Journal, Source Type: news
B.C. man sues Monsanto, Bayer, alleging Roundup herbicide caused his cancer
Cliff Sissons of Cranbrook, B.C., is suing the makers of the well-used herbicide, alleging exposure over the years caused him to develop non-Hodgkin's lymphoma. The maker of Roundup says the product is safe. (Source: CBC | Health)
Source: CBC | Health - October 18, 2019 Category: Consumer Health News Tags: News/Canada/British Columbia Source Type: news
Recent Research on Diabetes Mellitus, Non-Hodgkin Lymphoma Link
After conflicting opinions over the years, a study published in the journal Hematology explores the association between diabetes mellitus non-hodgkin lymphoma. (Source: CancerNetwork)
Source: CancerNetwork - October 18, 2019 Category: Cancer & Oncology Authors: Leanne Marcello, MS Source Type: news
Change the'Asymptomatic' Label for Rare Lymphoma Status Change the'Asymptomatic' Label for Rare Lymphoma Status
Patients with a rare form of non-Hodgkin lymphoma who are followed with observation are labeled ' asymptomatic, ' but they are rarely symptom free.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 10, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Opportunistic Infections, Is Non Hodgkin Lymphoma One of the Risk Factors for Mortality?
Conference abstracts (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 8, 2019 Category: Respiratory Medicine Authors: MeganB Source Type: news
Itraconazole, an Oral Antifungal Drug, Is Active in Chemotherapy Resistant B-Cell Non-Hodgkin Lymphoma and Enhances the Anti-Tumor Activity of Chemotherapy Agents
Conference abstracts (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 4, 2019 Category: Respiratory Medicine Authors: MeganB Source Type: news
